Abstract
Objective: The study consists in the analysis of the main regulatory acts governing personnel safety in pharmaceutical organizations. In the process of managing a pharmaceutical organization, the leader must rely on the requirements of current legislation in the field of personnel safety. Safety is the main strategic activity of any pharmaceutical organization. The legal framework governing personnel security is constantly expanding. Actually study the fundamental standards of personnel safety.
 Methods: The methods of analysis were a systematic approach, logical grouping, content analysis of the main documents regulating personnel security in the pharmaceutical industry.
 Results: The fundamental regulatory acts were identified that play a major role in ensuring and regulating the personnel safety of pharmaceutical organizations. Personnel security is a key element of the economic security of a pharmaceutical organization. The management of pharmaceutical personnel in the personnel safety system consists in finding ways to minimize risks and threats from and in relation to employees. The basic regulatory acts in the system of personnel security are identified, which allow to level threats and optimize the sustainable development of the pharmaceutical organization.
 Conclusion: In Russia, the legal basis for the personnel security of pharmaceutical organizations is: the Constitution; international treaties; federal constitutional laws; federal laws and regulations; Government Decisions; laws and other regulatory legal acts of entities. The term “security” is introduced by the law “On Security”. The main security threats are identified in the Economic Security Strategy for the period until 2030.
Highlights
By the Government of the Russian Federation, it is given big attention to healthcare sphere and including to the development of the pharmaceutical market
Personnel security is a key element of the economic security of a pharmaceutical organization
The confirmed strategy of development of pharmaceutical industry of the Russian Federation for the period until 2030 assumes realization of the sequence of strategic events which will allow to leave on qualitatively new level of the development of the pharmaceutical market and provision of the population of the Russian Federation by medical products
Summary
By the Government of the Russian Federation, it is given big attention to healthcare sphere and including to the development of the pharmaceutical market. The confirmed strategy of development of pharmaceutical industry of the Russian Federation for the period until 2030 assumes realization of the sequence of strategic events which will allow to leave on qualitatively new level of the development of the pharmaceutical market and provision of the population of the Russian Federation by medical products. Pharmaceutical clusters began to form actively in various regions of Russia after the approval of the development strategy of the pharmaceutical industry of the Russian Federation [1]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
